Mitohealth

Mitohealth sells at-home biomarker test kits and subscription-based longevity supplements. Core offerings include whole-blood epigenetic panels, continuous-glucose-monitor bundles, and physician-formulated micronutrient blends priced from $199 for a single test to $349 for quarterly refill plans, situating the brand in the premium tier. All products are sold direct-to-consumer through mitohealth.com; no retail distribution is listed. The company positions itself as a “longevity concierge,” combining next-generation diagnostics with personalized supplement protocols reviewed by licensed physicians. Results dashboards translate methylation and metabolic data into actionable daily targets, and every kit includes a 30-minute tele-health consult to interpret scores and adjust regimens. This integration of testing, clinical guidance and targeted nutrition in one flow is the brand’s primary differentiator. Customers are 30-55-year-old high-earning professionals who track sleep, exercise and diet via wearables and want quantified proof that their supplement spend is moving biomarkers. They value autonomy, evidence-based protocols and concierge access without wait-listed longevity clinics. Mitohealth competes with two cohorts: direct-mail blood-spot vitamin labs that lack physician follow-through, and premium nootropic or longevity pill brands that skip testing. By locking testing, interpretation and product into a single vertically integrated loop, it justifies higher price points and reduces the friction of piecing together separate lab, doctor and supplement orders.